C-myc deregulation is implicated in the pathogenesis of many tumors. One goal of the proposal is to investigate the non-structural, reversible deregulation of c-myc expression in a murine model system and to determine its importance to human carcinogenesis. An equally important goal is to foster the developing scientific abilities and independence of the applicant. To achieve the first goal, a logical series of experiments based on preliminary data from a model system, has been proposed. In the model system, chronic expression of activated ras is associated with non- structural, reversible deregulation of c-myc. Therefore, the investigation's specific aims are: 1) to identify the molecular mechanism(s) by which c-myc deregulation occurs in the model system; 2) to identify the molecular mechanism(s) by which reversion occurs; 3) to determine the importance of both deregulation and reregulation to human tumors; 4) to begin to investigate the role played by activated ras in non-structural c-myc deregulation. To achieve the second goal, an enthusiastic, dedicated and capable applicant is fortunate to be situated in an outstanding training position. The applicant, who had no experience with basic research prior to the research component of her hematology/ oncology fellowship, has, in a relatively short time, acquired many of the skills required to be a successful and productive scientist, and has demonstrated her commitment to a career with a substantial research component. To become fully independent and compete successfully for research grants, however, she needs additional training, including a mentor who can provide close supervision and a stimulating environment. The sponsor has an excellent record of scientific achievement, both in terms of his own investigations and his ability and commitment to train junior personnel. The laboratory is stimulating and productive. The institution is committed to support basic research in general and this applicant in particular. Awarding a CIA to this applicant would, in the short term, increase our knowledge of c- myc's role in tumorigenesis. In the long term it is likely to increase our understanding of oncogenes and tumor development more generally as the applicant establishes a career as a productive and independent cancer biologist.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08CA062179-05
Application #
2748751
Study Section
Cancer Institutional Fellowship Review Committee (CT)
Program Officer
Myrick, Dorkina C
Project Start
1994-08-22
Project End
2000-07-31
Budget Start
1998-08-01
Budget End
2000-07-31
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Boston University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Rosenberg, C L; Finnemore, E M; Larson, P S et al. (2000) DNA alterations in tumor scrapes vs. biopsies of squamous-cell carcinomas of the head and neck. Int J Cancer 89:105-10
Zucca, M P; Larson, P S; Rosenberg, C L et al. (1999) Lack of correlation between morphometric analysis and presence of microsatellite alterations in proliferative ductal lesions of the breast. Anal Quant Cytol Histol 21:369-73
Lazar, A D; Winter, M R; Nogueira, C P et al. (1998) Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease. Clin Cancer Res 4:2787-93
Larson, P S; de las Morenas, A; Cupples, L A et al. (1998) Genetically abnormal clones in histologically normal breast tissue. Am J Pathol 152:1591-8
Rosenberg, C L; Larson, P S; Romo, J D et al. (1997) Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer. Hum Pathol 28:214-9
Rosenberg, C L; de las Morenas, A; Huang, K et al. (1996) Detection of monoclonal microsatellite alterations in atypical breast hyperplasia. J Clin Invest 98:1095-100